[Chemotherapy of pleuro-pulmonary metastases].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010166:Palliative Care; D010997:Pleural Neoplasms; D011379:Prognosis; D013997:Time Factors
D000970:Antineoplastic Agents; D003609:Dactinomycin; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Chimiothérapie des métastases pleuro-pulmonaires.